These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3491536)

  • 1. Antibody response to measles vaccine with DTPP.
    John TJ; Selvakumar R; Balrai V; Simoes EA
    Am J Dis Child; 1987 Jan; 141(1):14. PubMed ID: 3491536
    [No Abstract]   [Full Text] [Related]  

  • 2. Mixing measles vaccine with DPT and DPTP.
    John TJ; Selvakumar R
    Lancet; 1985 May; 1(8438):1154. PubMed ID: 2860353
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody response of children to measles vaccine mixed with diphtheria-pertussis-tetanus or diphtheria-pertussis-tetanus-poliomyelitis vaccine.
    Simoes EA; Balraj V; Selvakumar R; John TJ
    Am J Dis Child; 1988 Mar; 142(3):309-11. PubMed ID: 3257842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine.
    Robertson SE; Traverso HP; Drucker JA; Rovira EZ; Fabre-Teste B; Sow A; N'Diaye M; Sy MT; Diouf F
    Lancet; 1988 Apr; 1(8591):897-9. PubMed ID: 2895828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractional doses of DPT vaccine.
    Wassilak S; Brink EW
    CMAJ; 1985 Oct; 133(7):642. PubMed ID: 3876148
    [No Abstract]   [Full Text] [Related]  

  • 7. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antibody response of seronegative infants to inactivated poliovirus vaccine of enhanced potency.
    Simoes EA; John TJ
    J Biol Stand; 1986 Apr; 14(2):127-31. PubMed ID: 3020057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
    Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why children are not immunised.
    Hull D
    J R Coll Physicians Lond; 1987 Jan; 21(1):28-31. PubMed ID: 3493341
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antibody response to the fractionated administration of the 2d or 3d basic vaccination injection with a mixed vaccine against diphtheria, tetanus and pertussis].
    Vodicková M; Svandová E
    Cesk Pediatr; 1986 Jun; 41(6):321-3. PubMed ID: 2872973
    [No Abstract]   [Full Text] [Related]  

  • 13. [Status of immunization of ten-year-olds against poliomyelitis, diphtheria, tetanus, pertussis, measles and mumps].
    Schmitt L
    Offentl Gesundheitswes; 1984 Oct; 46(10):494-6. PubMed ID: 6239116
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tetravalent diphtheria, tetanus, pertussis and inactivated poliomyelitis vaccine].
    Fillastre C; Brégère P; Guérin N
    Arch Fr Pediatr; 1989 Nov; 46(9):693-700. PubMed ID: 2604532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants.
    Lang J; Duong GH; Nguyen VG; Le TT; Nguyen CV; Kesmedjian V; Plotkin SA
    Lancet; 1997 Jun; 349(9066):1663-5. PubMed ID: 9186385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in worldwide control and elimination of disease through immunization.
    Hayden GF; Sato PA; Wright PF; Henderson RH
    J Pediatr; 1989 Apr; 114(4 Pt 1):520-7. PubMed ID: 2647942
    [No Abstract]   [Full Text] [Related]  

  • 19. Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV).
    Knuf M; Vetter V; Celzo F; Ramakrishnan G; Van Der Meeren O; Jacquet JM
    Hum Vaccin; 2010 Jul; 6(7):554-61. PubMed ID: 20448468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A calendar of prophylactic inoculations in wide practical use].
    Chudnaia LM; Shekhter AB; Krasiuk LS; Oksiiuk VG; Fastovskaia BN
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jan; (1):37-41. PubMed ID: 3259058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.